Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

How do fibrates act and what are their effects on HDL-C?

Fibrates act by activating PPAR-α, a nuclear receptor that shifts liver metabolism toward fatty acid oxidation and enhances lipoprotein processing. This leads to reduced production of VLDL in the liver and greater breakdown of triglyceride-rich particles by lipoprotein lipase, so plasma triglycerides fall. Activation of PPAR-α also boosts production of apolipoproteins A-I and A-II and improves reverse cholesterol transport, which modestly raises HDL-C. In practice, the HDL-C increase is modest, often around 10–20%, while triglycerides drop more significantly. Other mechanisms described—like statins inhibiting HMG-CoA reductase, PPAR-γ agonists raising TG, or SREBP inhibitors—do not describe how fibrates work.

Fibrates act by activating PPAR-α, a nuclear receptor that shifts liver metabolism toward fatty acid oxidation and enhances lipoprotein processing. This leads to reduced production of VLDL in the liver and greater breakdown of triglyceride-rich particles by lipoprotein lipase, so plasma triglycerides fall. Activation of PPAR-α also boosts production of apolipoproteins A-I and A-II and improves reverse cholesterol transport, which modestly raises HDL-C. In practice, the HDL-C increase is modest, often around 10–20%, while triglycerides drop more significantly. Other mechanisms described—like statins inhibiting HMG-CoA reductase, PPAR-γ agonists raising TG, or SREBP inhibitors—do not describe how fibrates work.